Fundraising Fox
Nanovis
Columbia City, US · 5 known investors
Find your way into Nanovis
Sign up to see every warm intro you have to Nanovis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanovis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanovis develops and manufactures nanoscale surface technologies designed to improve the integration of orthopedic, spinal, and dental implants. It supplies these implant surface technologies to medical device makers and OEM partners in the medtech industry.
Founders & leadership
MH
Matthew HedrickChief Executive Officer and President
BM
Brian MoreChief Executive OfficerBrian More is Chief Financial Officer of Nanovis, which develops nanoscale surface technologies for orthopedic, spinal, and dental implants. He brings over two decades of accounting and finance experience, including roles as staff accountant, controller, and ISO management representative.
Board
BE
Brian EmerickChairman of Board
SG
Steve GerrishBoard Member
Investors · 5
Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M
How we know: funding news · prweb.com · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 4
1st Source Capital CorporationCommenda CapitalEllipsis VenturesPurdue's Foundry Investment Fund
Funding
SEC filings, press & company announcements$16.4M disclosed across 7 of 8 rounds · 2014–2020
- $5.5MraisedAug 2018 · 3 sources
1st Source Capital Corporation, Commenda Capital, Elevate Ventures, Ellipsis Ventures, Purdue's Foundry Investment Fund
Source ↗
▶$5.4MraisedMar 2020 · 5 investors · BiotechnologyRule 506(b)
▶$5.4MraisedMar 2020 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CHRISTOPHER LAMOTHEDirector
- V. EDWARD GROGGDirector
- BRIAN EMERICKExecutive Officer, Director
- MATTHEW HEDRICKExecutive Officer, Director
- BRIAN MOREExecutive Officer, Director
- Amount sold
- $5.4M
- Minimum investment
- $50K
- Sales commissions
- $220K
- Proceeds to insiders
- $237K
- Placement agents
- COMMENDA SECURITIES, LLC
- First sale
- Feb 2020
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
▶$769.5KraisedSep 2017 · 5 investors · BiotechnologyRule 506(b)
▶$769.5KraisedSep 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew HedrickExecutive Officer, Director
- Brian EmerickDirector, Promoter
- v Edward GroggDirector
- Brian MoreExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $769.5K
- Minimum investment
- $50K
- Sales commissions
- $440K
- Proceeds to insiders
- $237K
- Placement agents
- Commenda Securities, LLC
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
▶$1.1MraisedSep 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1.1MraisedSep 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew HedrickExecutive Officer, Director
- Brian EmerickDirector, Promoter
- V. Edward GroggDirector
- Brian MoreExecutive Officer, Director
- Steve GerrishDirector
- Offering amount
- $2.8M
- Amount sold
- $1.1M
- Minimum investment
- $100K
- Proceeds to insiders
- $30K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
▶$3.8MofferedSep 2016 · BiotechnologyRule 506(b)
▶$3.8MofferedSep 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steve GerrishDirector
- Brian EmerickDirector, Promoter
- Brian MoreExecutive Officer, Director
- Matthew HedrickExecutive Officer, Director
- V. Edward GroggDirector
- Offering amount
- $3.8M
- Minimum investment
- $50K
- Proceeds to insiders
- $100K
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
▶$750KraisedDec 2015 · 1 investors · BiotechnologyRule 506(b)
▶$750KraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian MoreExecutive Officer
- Steve GerrishDirector
- Matthew HedrickExecutive Officer, Promoter
- V. Edward GroggDirector
- Brian EmerickDirector, Promoter
- Offering amount
- $2.5M
- Amount sold
- $750K
- Minimum investment
- $50K
- Proceeds to insiders
- $75K
- First sale
- Nov 2015
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$2.5MraisedJan 2015 · 1 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian EmerickDirector, Promoter
- Matthew HedrickExecutive Officer, Director, Promoter
- Brian MoreExecutive Officer, Director
- Steve GerrishDirector
- Offering amount
- $3.8M
- Amount sold
- $2.5M
- Minimum investment
- $50K
- Proceeds to insiders
- $122.5K
- First sale
- Dec 2014
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
▶$372.1KraisedAug 2014 · 5 investors · BiotechnologyRule 506(b)
▶$372.1KraisedAug 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian EmerickDirector, Promoter
- Matthew HedrickExecutive Officer, Director, Promoter
- Steve GerrishDirector
- Brian MoreExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $372.1K
- Minimum investment
- $5K
- Proceeds to insiders
- $50K
- First sale
- Jul 2014
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
NuvasiveNuVasive provides intraoperative neuromonitoring (IONM) services and implantable orthopedic and spinal devices for hospitals, surgeons, and patients, supported by board-certified neurologists and neurophysiologists. The company is transitioning its operations to Globus Medical.
Companies working in the same space as Nanovis.
Frequently asked questions
- What does Nanovis do?
- Nanovis develops and manufactures nanoscale surface technologies designed to improve the integration of orthopedic, spinal, and dental implants. It supplies these implant surface technologies to medical device makers and OEM partners in the medtech industry.
- Who are Nanovis's investors?
- Nanovis's investors include Elevate Ventures.
- How much funding has Nanovis raised?
- Nanovis has disclosed $16.4M raised across 7 of its 8 known rounds.
- Where is Nanovis headquartered?
- Nanovis is headquartered in Columbia City, US.